Samuel Searcy

Samuel Searcy currently serves as a Senior Advisor at NeuroVice, focusing on commercialization and exit strategies in the pediatric epileptic medical device sector. Concurrently, Samuel holds the position of Chief Commercial Officer at Elixia, where the organization specializes in clinical trials across various medical fields and aims to enhance data collection and access for diverse populations. Samuel has also contributed to ICE Global Consulting, Inc. as a Board Director and previously served as CEO of CliniStart. Samuel's political experience includes a tenure as a Senator in the North Carolina General Assembly, advocating for legislation benefiting life sciences and healthcare. Notable past roles include Director at IQVIA, Chairman of WCG, and Associate Director for Europe and Asia-Pacific at PRA Health Sciences. Samuel holds a Juris Doctor from The University of Tulsa College of Law, a degree in International Business Transactions from Bucerius Law School, and a Bachelor of Arts from Appalachian State University.